306 related articles for article (PubMed ID: 25634174)
1. Prostate tumor overexpressed 1 is a novel prognostic marker for hepatocellular carcinoma progression and overall patient survival.
Chen SP; Zhang LS; Fu BS; Zeng XC; Yi HM; Jiang N
Medicine (Baltimore); 2015 Jan; 94(4):e423. PubMed ID: 25634174
[TBL] [Abstract][Full Text] [Related]
2. Prostate Tumor Overexpressed 1 (PTOV1) Is a Novel Prognostic Marker for Nasopharyngeal Carcinoma Progression and Poor Survival Outcomes.
Yang Q; Lin H; Wu S; Lei F; Zhu X; Song L; Hong M; Guo L
PLoS One; 2015; 10(8):e0136448. PubMed ID: 26305455
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer.
Lei F; Zhang L; Li X; Lin X; Wu S; Li F; Liu J
BMC Cancer; 2014 Jun; 14():457. PubMed ID: 24947166
[TBL] [Abstract][Full Text] [Related]
4. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
5. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
6. Chromobox homolog 4 is correlated with prognosis and tumor cell growth in hepatocellular carcinoma.
Wang B; Tang J; Liao D; Wang G; Zhang M; Sang Y; Cao J; Wu Y; Zhang R; Li S; Ding W; Zhang G; Kang T
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S684-92. PubMed ID: 23943028
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
[TBL] [Abstract][Full Text] [Related]
8. Epithelial to mesenchymal transition is associated with shorter disease-free survival in hepatocellular carcinoma.
Yamada S; Okumura N; Wei L; Fuchs BC; Fujii T; Sugimoto H; Nomoto S; Takeda S; Tanabe KK; Kodera Y
Ann Surg Oncol; 2014 Nov; 21(12):3882-90. PubMed ID: 24833103
[TBL] [Abstract][Full Text] [Related]
9. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
[TBL] [Abstract][Full Text] [Related]
10. High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy.
Wang H; Jiang S; Zhang Y; Pan K; Xia J; Chen M
World J Surg Oncol; 2014 Jul; 12():226. PubMed ID: 25037578
[TBL] [Abstract][Full Text] [Related]
11. Expression of HSPA2 in human hepatocellular carcinoma and its clinical significance.
Fu Y; Zhao H; Li XS; Kang HR; Ma JX; Yao FF; Du N
Tumour Biol; 2014 Nov; 35(11):11283-7. PubMed ID: 25117073
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of Spondin-2 protein expression correlates with poor prognosis in hepatocellular carcinoma.
Feng Y; Hu Y; Mao Q; Guo Y; Liu Y; Xue W; Cheng S
J Int Med Res; 2019 Feb; 47(2):569-579. PubMed ID: 30318967
[TBL] [Abstract][Full Text] [Related]
13. Expression of cytoskeleton regulatory protein Mena in human hepatocellular carcinoma and its prognostic significance.
Hu K; Wang J; Yao Z; Liu B; Lin Y; Liu L; Xu L
Med Oncol; 2014 May; 31(5):939. PubMed ID: 24683008
[TBL] [Abstract][Full Text] [Related]
14. [Up-regulator of cell proliferation predicts poor prognosis in hepatocellular carcinoma].
Xie C; Li J; Xie DY; Lin BL; Li MF; Gao ZL
Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(27):2167-73. PubMed ID: 24284254
[TBL] [Abstract][Full Text] [Related]
15. Prostate tumor overexpressed 1 expression in invasive urothelial carcinoma.
Rausch S; Hennenlotter J; Scharpf M; Teepe K; Kühs U; Aufderklamm S; Bier S; Mischinger J; Gakis G; Stenzl A; Schwentner C; Todenhöfer T
J Cancer Res Clin Oncol; 2016 May; 142(5):937-47. PubMed ID: 26746655
[TBL] [Abstract][Full Text] [Related]
16. Expression Pattern and Clinical Significance of Gab2 Protein in Hepatocellular Carcinoma.
Hu X; He B; Zhou L; Xie H; Zheng S
Clin Lab; 2016; 62(6):1087-92. PubMed ID: 27544933
[TBL] [Abstract][Full Text] [Related]
17. EIF4EBP1 overexpression is associated with poor survival and disease progression in patients with hepatocellular carcinoma.
Cha YL; Li PD; Yuan LJ; Zhang MY; Zhang YJ; Rao HL; Zhang HZ; Zheng XF; Wang HY
PLoS One; 2015; 10(2):e0117493. PubMed ID: 25658620
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of MAGE-D4 expression in hepatocellular carcinoma in Japanese patients.
Takami H; Kanda M; Oya H; Hibino S; Sugimoto H; Suenaga M; Yamada S; Nishikawa Y; Asai M; Fujii T; Nomoto S; Kodera Y
J Surg Oncol; 2013 Dec; 108(8):557-62. PubMed ID: 24068544
[TBL] [Abstract][Full Text] [Related]
19. Dyskerin overexpression in human hepatocellular carcinoma is associated with advanced clinical stage and poor patient prognosis.
Liu B; Zhang J; Huang C; Liu H
PLoS One; 2012; 7(8):e43147. PubMed ID: 22912812
[TBL] [Abstract][Full Text] [Related]
20. Promoter hypomethylation up-regulates CD147 expression through increasing Sp1 binding and associates with poor prognosis in human hepatocellular carcinoma.
Kong LM; Liao CG; Chen L; Yang HS; Zhang SH; Zhang Z; Bian HJ; Xing JL; Chen ZN
J Cell Mol Med; 2011 Jun; 15(6):1415-28. PubMed ID: 20629990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
